Quantitative Biosciences Institute Appoints Brad Schneider, Ph.D., as Chief Operating Officer
The Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF) today announced the appointment of Brad Schneider, Ph.D., as Chief Operating Officer. Dr. Schneider brings more than two decades of experience in infectious disease research, global health operations, and scientific program leadership to his new role.
Quantitative Biosciences Institute Appoints Andy Kilianski, Ph.D., as Chief Science and Technology Officer
The Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF) today announced the appointment of Andy Kilianski, Ph.D., as Chief Science and Technology Officer. Dr. Kilianski brings over a decade of distinguished experience spanning academic virology, national security, and translational research leadership, making him uniquely positioned to advance QBI’s mission of translating cutting-edge integrative science into transformative therapies and public health impact.
Quantitative Biosciences Institute Appoints John A.T. Young, Ph.D., as Chief Strategy Officer
The Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF) today announced the appointment of John A.T. Young, Ph.D., as Chief Strategy Officer. Dr. Young brings over three decades of distinguished experience spanning academic research, pharmaceutical R&D leadership, and global public health, making him uniquely positioned to advance QBI’s mission of translating cutting-edge protein-protein interaction (PPI) science into transformative therapies.
